Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

A Primer on Biological Weapons for the Clinician, Part I

O'Byrne WT, Terndrup TE, Kiefe CI, Weissman NW. A Primer on Biological Weapons for the Clinician, Part I. Johns Hopkins Advanced Studies in Medicine. 2003 Feb 1; 3:75-86.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

Although the thought of an outbreak of disease caused by the intentional release of a pathogen in a major American city was alien a decade ago, the purposeful release of anthrax via the US Postal Service and the resulting deaths from inhalation anthrax have caused a sea change in thinking about biological weapons and 'bioweaponeers.' Most experts agree that a biological attack is imminent and the toll in suffering and death potentially great. In the event of a bioterrorist attack, the emergency physician and the hospital will most likely be the first clinical responders. However, some biologic agents produce initial symptoms that are nonspecific and thus may not have a high index of suspicion until severe morbidity or fatality results. It is imperative, then, that individual outpatient and ambulatory care providers consider biologic agents whenever a patient presents with nonspecific constitutional symptoms. Tbis is particularly true of physicians whose practices are comprised mainly of elderly or older adult patients. Internists, family physicians, geriatricians, and others who care for elderly people will face unique clinical challenges when faced with an attack involving a biologic agent. The purpose of this article is to address the needs of internists, family physicians, geriatricians, and their counterparts with concise and current information on the Centers for Disease Control Category A pathogens, taking into account diagnostic challenges germane to elderly populations.





Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.